Cargando…

Editorial: Psychiatric and Pharmacotoxicological Insights on Appearance and Performance Enhancing Drugs

Detalles Bibliográficos
Autores principales:	Zaami, Simona, Di Trana, Annagiulia, García-Algar, Óscar, Marinelli, Enrico, Busardò, Francesco Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178271/ https://www.ncbi.nlm.nih.gov/pubmed/35693973 http://dx.doi.org/10.3389/fpsyt.2022.918482

Ejemplares similares

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Editorial: New Trends of Substance Abuse: Looking for New Psychotropic Effects of Chem Sex Drugs, Cognitive Enhancers, and New Psychoactive Substances
por: Pichini, Simona, et al.
Publicado: (2020)

Synthetic Benzimidazole Opioids: The Emerging Health Challenge for European Drug Users
por: Di Trana, Annagiulia, et al.
Publicado: (2022)

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances
por: Di Trana, Annagiulia, et al.
Publicado: (2020)

Effects of Appearance- and Performance-Enhancing Drugs on Personality Traits
por: Zaami, Simona, et al.
Publicado: (2021)

Use of Methylphenidate Analogues as Cognitive Enhancers: The Prelude to Cosmetic Neurology and an Ethical Issue
por: Zaami, Simona, et al.
Publicado: (2020)

Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids
por: Solimini, Renata, et al.
Publicado: (2018)

Intensive and pharmacological care in times of COVID-19: A “special ethics” for emergency?
por: Marinelli, Enrico, et al.
Publicado: (2020)

Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances
por: Di Trana, Annagiulia, et al.
Publicado: (2022)

New Trends of Substance Abuse During COVID-19 Pandemic: An International Perspective
por: Zaami, Simona, et al.
Publicado: (2020)

The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs
por: Negro, Francesca, et al.
Publicado: (2021)

Editorial: The Challenge Posed by New Synthetic Opioids: Pharmacology and Toxicology
por: Pichini, Simona, et al.
Publicado: (2019)

Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans
por: Di Giorgi, Alessandro, et al.
Publicado: (2023)

When “Chems” Meet Sex: A Rising Phenomenon Called “ChemSex”
por: Giorgetti, Raffaele, et al.
Publicado: (2017)

Toxicological Characterization of GHB as a Performance-Enhancing Drug
por: Giorgetti, Arianna, et al.
Publicado: (2022)

Editorial: Insights in social psychiatry and psychiatric rehabilitation: 2021
por: Vita, Antonio
Publicado: (2022)

Recent Trends in Analytical Methods to Determine New Psychoactive Substances in Hair
por: Kyriakou, Chrystalla, et al.
Publicado: (2017)

Editorial: Adult ADHD and other psychiatric disorders
por: Oliva, Francesco, et al.
Publicado: (2022)

Psychomotor performances relevant for driving under the combined effect of ethanol and synthetic cannabinoids: A systematic review
por: Giorgetti, Arianna, et al.
Publicado: (2023)

Cardiovascular Outcomes in Advanced Maternal Age Delivering Women. Clinical Review and Medico-Legal Issues
por: De Viti, Daniele, et al.
Publicado: (2019)

The challenging issue of polydrug consumption: new trends of a deep-seated public health threat
por: Di Trana, Annagiulia
Publicado: (2022)

Editorial: Psychiatric Disorder in Veterans
por: Pasinetti, Giulio M., et al.
Publicado: (2021)

LC-MS/MS Application in Pharmacotoxicological Field: Current State and New Applications
por: D’Ovidio, Cristian, et al.
Publicado: (2023)

Amniotic Fluid Embolism Pathophysiology Suggests the New Diagnostic Armamentarium: β-Tryptase and Complement Fractions C3-C4 Are the Indispensable Working Tools
por: Busardò, Francesco Paolo, et al.
Publicado: (2015)

Editorial: Psychomotor Symptomatology in Psychiatric Illnesses
por: Walther, Sebastian, et al.
Publicado: (2015)

Editorial: Cognitive Enhancement in Psychiatric Disorders
por: Sumiyoshi, Tomiki, et al.
Publicado: (2019)

Editorial: Novel Technology in Psychiatric Rehabilitation
por: Tsang, Hector W. H., et al.
Publicado: (2022)

Editorial: Neuroinflammation, metabolism, and psychiatric disorders
por: Freyberg, Zachary, et al.
Publicado: (2022)

Editorial: Cardiometabolic disease and psychiatric disorders
por: Deste, Giacomo, et al.
Publicado: (2023)

Editorial: Neurocognitive deficits in psychiatric disorders
por: Yang, Jie
Publicado: (2023)

Role of Vanadium in Cellular and Molecular Immunology: Association with Immune-Related Inflammation and Pharmacotoxicology Mechanisms
por: Tsave, Olga, et al.
Publicado: (2016)

Cocaine: An Updated Overview on Chemistry, Detection, Biokinetics, and Pharmacotoxicological Aspects including Abuse Pattern
por: Roque Bravo, Rita, et al.
Publicado: (2022)

The Evolution of Legislation in the Field of Medically Assisted Reproduction and Embryo Stem Cell Research in European Union Members
por: Busardò, Francesco Paolo, et al.
Publicado: (2014)

Smart Drugs and Synthetic Androgens for Cognitive and Physical Enhancement: Revolving Doors of Cosmetic Neurology
por: Frati, Paola, et al.
Publicado: (2015)

Editorial: Brain and Somatization Symptoms in Psychiatric Disorders
por: Fu, Xiaoya, et al.
Publicado: (2019)

Editorial: Problematic Gaming, Personality, and Psychiatric Disorders
por: Starcevic, Vladan, et al.
Publicado: (2020)

Editorial: Low-Intensity Interventions for Psychiatric Disorders
por: Sijbrandij, Marit, et al.
Publicado: (2020)

Editorial: Psychiatric disorders of chronic physical diseases
por: Song, Dan, et al.
Publicado: (2023)

Editorial: Long term psychiatric care and COVID-19
por: Lega, Ilaria, et al.
Publicado: (2022)

Editorial: Understanding perinatal mental health psychiatric impact
por: Wickham, Robert J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_btgssdqi5tn3vu1onkgf5r6qe0